PRMT1 and hepatocellular carcinoma: The transcriptional activity of YAP and TEAD were further characterized by real‐time qPCR and immunofluorescence assay, and a subcutaneous and orthotopic tumor mouse model was used to assess the effect of PRMT1‐knockdown on HCC tumor growth.